Newmarket Strategy
Newmarket Strategy is a London-based life sciences consultancy founded in 2021, providing strategic advice and technical support to pharmaceutical, biotechnology, medical devices, and healthcare clients. The firm is founder-led and received investment from Baird Capital in January 2025.
- Company typePrivate
- Founded2021
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Newmarket Strategy does
Newmarket Strategy is a London-based specialist consultancy providing strategic advice and technical support to the life sciences sector, including pharmaceutical, biotechnology, medical devices, and healthcare organizations. The firm was founded in 2021 and operates with a headcount of 11-50 employees, structured around three co-founders — Ed Jones, James O'Shaughnessy, and Berkeley Greenwood — who each serve as Co-Founder and Senior Partner. The firm targets a single vertical segment (life sciences) and is registered as a private, venture capital-backed company headquartered in London, United Kingdom.
The firm received its first disclosed institutional capital from Baird Capital in January 2025, with the round type and amount undisclosed. No specific service lines, methodologies, proprietary frameworks, or technology platforms are documented in the source data, and pricing models, customer logos, and revenue figures are not publicly disclosed. No products, software offerings, or AI/ML capabilities are referenced, and the firm's go-to-market and revenue mechanics are not described beyond its general positioning as a life sciences consultancy.
The available evidence supports a profile of a small, founder-led, domain-specialist advisory firm in the early-to-mid scaling phase, having secured a single institutional investor to support continued growth. Key gaps in the data set — including revenue, headcount trend, named clients, pricing, and product/service detail — limit further characterization of operating model and competitive positioning.
Newmarket Strategy firmographics
Firmographics- Name
- Newmarket Strategy
- Legal name
- Newmarket Strategy
- Website
- https://newmarket-strategy.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Newmarket Strategy is a London-based life sciences consultancy founded in 2021, providing strategic advice and technical support to pharmaceutical, biotechnology, medical devices, and healthcare clients. The firm is founder-led and received investment from Baird Capital in January 2025.
- Ownership category
- akta.pro rank
Newmarket Strategy industry classification
Industry- Product category
- Life Sciences Consulting
- NAICS
- Management Consulting Services (54161), Other Management Consulting Services (541618), Management, Scientific, and Technical Consulting Services (5416)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Strategy & Corporate Development Consulting (BPAHACAA)
- akta.pro secondary industries
- Competitive Intelligence & Benchmarking (BPAHALAB), Corporate Strategy Advisory (BPAHADAA)
Keywords
Where Newmarket Strategy is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Newmarket Strategy business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Newmarket Strategy product offering
Product offeringCore offering
Newmarket Strategy provides strategic advisory and technical support services to clients in the healthcare, life sciences, and health technology sectors. The firm advises pharmaceutical, biotechnology, medical device, and healthcare organizations on strategic matters relevant to their businesses.
Differentiator
Problem solved
Functional benefit
Products and services
- Strategic Advisory and Technical Support Services Strategic advice and technical support services delivered to organizations in the healthcare, life sciences, and health technology sectors, including pharmaceutical, biotechnology, medical device, and healthcare companies.
Companies that use Newmarket Strategy
Customer profileSegments1 record
Ideal customer profiles1 record
Newmarket Strategy technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Newmarket Strategy partnerships and signals
Strategic signalRecent moves2 records
Expansion highlights1 record
Newmarket Strategy competitors and assessment
Company assessmentBroad incumbents
- Parexel International: Large clinical research and biopharmaceutical services firm that also provides commercial strategy and consulting support to life sciences clients. Adjacent incumbent with overlapping pharma/biotech client base and advisory services.
- Bain & Company (Healthcare Practice): Global strategy consultancy with a deep Healthcare and Life Sciences practice advising pharma, biotech, and providers. Comparable client overlap and strategic advisory scope, but a broader portfolio firm.
- McKinsey & Company (Life Sciences Practice): Global management consulting giant with a dedicated Pharmaceuticals & Medical Products practice serving many of the same pharma, biotech, and medtech clients as Newmarket, but at vastly greater scale and breadth. Sets competitive benchmarks for the niche.
Direct peers
- LEK Consulting: Global strategy consulting firm with one of the largest dedicated life sciences and healthcare practices. Directly comparable as a specialist strategy advisor to pharma, biotech, and medical device clients on commercial, R&D, and corporate strategy issues.
- Putnam Associates: Specialist life sciences strategy consultancy providing commercial strategy, pricing, and market access advice to global pharma and biotech. Comparable boutique model and therapeutic-area-deep service offering.
- Health Advances: Boutique healthcare and life sciences strategy consulting firm advising medtech, pharma, and diagnostics clients on portfolio strategy, market entry, and commercialization. Direct comparable in scale and specialization.
- Trinity Life Sciences: US-headquartered life sciences strategy and insights consultancy serving pharma and biotech with commercial strategy, market access, and evidence solutions. Closely comparable niche focus and service mix to Newmarket Strategy.
- Charles River Associates: Global consulting firm with a prominent life sciences practice delivering strategic and economic advisory services to pharma, biotech, and medical device companies. Comparable in life sciences strategy depth and client base.
- ClearView Healthcare Partners: Boutique strategy consulting firm focused exclusively on life sciences, advising biopharma clients on commercial strategy, pipeline prioritization, and new product planning. Direct competitor in the life sciences strategy niche.
- ZS Associates: Large global consulting firm with a deep healthcare and life sciences practice covering strategy, sales, and analytics for pharma, biotech, and medtech. Comparable in target clients and strategic advisory scope.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
Newmarket Strategy social profiles
Digital presenceNewmarket Strategy financial estimates
Financial estimateRevenue estimate
Valuation estimate
Newmarket Strategy leadership team
Management profileNumber of profiles
Profiles3 records
Newmarket Strategy funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Newmarket Strategy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Newmarket Strategy
What does Newmarket Strategy do?
Newmarket Strategy provides strategic advisory and technical support services to clients in the healthcare, life sciences, and health technology sectors. The firm advises pharmaceutical, biotechnology, medical device, and healthcare organizations on strategic matters relevant to their businesses.
Is Newmarket Strategy a public or private company?
Newmarket Strategy is a private company. It is classified as venture growth investor backed and is currently operating.
When was Newmarket Strategy founded?
Newmarket Strategy was founded in 2021. It employs 11 to 50 people.
Where is Newmarket Strategy based?
Newmarket Strategy is headquartered in London, United Kingdom, in the Europe region.
Who are Newmarket Strategy's main competitors?
Broad incumbents on record are Parexel International, Bain & Company (Healthcare Practice) and McKinsey & Company (Life Sciences Practice). Direct peers are LEK Consulting, Putnam Associates, Health Advances, Trinity Life Sciences, Charles River Associates, ClearView Healthcare Partners and ZS Associates.
Does Newmarket Strategy have an API?
No public API is recorded for Newmarket Strategy.
What industry is Newmarket Strategy in?
Newmarket Strategy's product category is Life Sciences Consulting. Its primary akta.pro industry code is BPAHACAA, Strategy & Corporate Development Consulting, with a secondary code of BPAHALAB, Competitive Intelligence & Benchmarking. Its NAICS code is 54161 and its SIC code is 8742.